Side-by-Side Comparison
| Metric | Mucosis | Osivax |
|---|---|---|
| Founded | ||
| Founded | 2006 older | 2017 |
| Headquarters | ||
| Headquarters | Not tracked yet | Lyon, France |
| Employees | ||
| Employees | Not tracked yet | 53 |
| Industry | ||
| Industry | Biotechnology, Health Care | Biotechnology, Health Care |
| Funding Stage | ||
| Funding Stage | Venture round | Grant |
| Total Funding | ||
| Total Funding | $15.60M | $53.30M |
| Funding Rounds | ||
| Funding Rounds | 3 | 7 |
| Taxonomy | ||
| Taxonomy | VaccinesIntranasal DeliveryMucosal VaccinesRespiratory Syncytial VirusMimopath TechnologyClinical-stage +8 | ImmunologyVaccineInfectious DiseasesPan-respiratory VirusCellular Immune ResponseCD8 T-cell +8 |
| Website | ||
| Website | mucosis.com | osivax.com |
About Mucosis
Mucosis B.V., founded in 2006, is a Dutch biotechnology company specializing in needle-free mucosal vaccines administered via the nose or mouth. Their flagship product, SynGEM®, an intranasal vaccine targeting respiratory syncytial virus infection, is based on the patented and validated Mimopath® te...
About Osivax
Osivax is a clinical-stage biopharmaceutical company founded in 2017, with its headquarters in France. The company is pioneering a new class of universal vaccines utilizing the oligoDOM® nanoparticle platform technology. Their flagship product, OVX836, a broad-spectrum "universal" influenza candidat...
Also comparing in this category
Comparing more than these two?
Get Mucosis, Osivax and up to nine more competitors side by side in one PDF: team, funding, traffic and every dated move of the last six months. Every company is re-checked on the day you order.
How does Mucosis compare?
A PDF of Mucosis and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.
This takes a few seconds: we look beyond our own index too.
Frequently Asked Questions
Compare Mucosis with someone else
Start typing a company name or domain.
Related Comparisons
Compiled from the BounceWatch company index. We last looked at Mucosis on 21 Jun 2024, and Osivax on 11 Sep 2024. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.
